Regeneron Pharmaceuticals (REGN) earnings date: expected January 27 – February 2

Regeneron Pharmaceuticals (REGN) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 27 – February 2. That is an estimate, not a confirmed date. Free email alerts for this report are just below.

Source: company filings and exchange data · Updated Nov 3, 2026

ATLAS view on REGN

Last price	$961.26 (+3.6%)
Normal 1-day range (±1σ)	±2.9%
Earnings beat history	Beat the EPS estimate in 4 of the last 6 reports
Dividend	$3.70 a year (0.38% yield) · next ex-date Nov 20, 2026

These figures come from the same calibrated model and valuation as the Regeneron Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.

Get an email before and after Regeneron Pharmaceuticals reports, free with your ATLAS account

Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.

Create free account

REGN earnings at a glance

Next report	Not announced · expected around January 27 – February 2 (ATLAS estimate)
Last report	Oct 30, 2026 · Beat
Beat rate (last 6 reports)	4 of 6 (67%)
Average EPS surprise	+12.3%
Average move around a report	±3.4% (last 5)
Sector	Healthcare · Biotechnology

The expected window is an ATLAS estimate: it takes the typical gap between Regeneron Pharmaceuticals’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.

Regeneron Pharmaceuticals earnings history: last 6 reports

Regeneron Pharmaceuticals last reported on Oct 30, 2026: EPS of $18.43 against an estimate of $13.76 (+33.9% surprise), a beat.

Report date	EPS est.	EPS actual	Surprise	Result	Move*
Oct 30, 2026	$13.76	$18.43	+33.9%	Beat	–
Jul 30, 2026	$10.21	$14.29	+40.0%	Beat	+9.7%
Apr 29, 2026	$8.90	$9.47	+6.4%	Beat	-3.4%
Apr 2, 2026	-$0.62	-$0.71	-14.5%	Miss	-1.8%
Jan 30, 2026	$10.75	$11.44	+6.4%	Beat	+0.7%
Jan 29, 2026	$6.45	$6.57	+1.9%	In line	-1.3%

*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.

Regeneron Pharmaceuticals latest earnings results

Regeneron Pharmaceuticals (REGN) Q3 2026 earnings results · reported Oct 30, 2026

Get the full ATLAS analysis for REGN

See the fair value, the probability range and the earnings history of Regeneron Pharmaceuticals on its ATLAS page.

Regeneron Pharmaceuticals (REGN) stock analysis

Plans from €3.99 a month.

Regeneron Pharmaceuticals earnings: frequently asked questions

When is Regeneron Pharmaceuticals (REGN) next earnings date?

Regeneron Pharmaceuticals has not announced its next report. Its last 4 reports came Oct 30, 2026, Jul 30, 2026, Apr 29, 2026, Jan 30, 2026, so ATLAS estimates the next one around January 27 – February 2. This is an estimate based on that pattern, not a confirmed date.

How often does REGN beat earnings estimates?

Of its last 6 reports with a recorded result, Regeneron Pharmaceuticals beat the EPS estimate 4 times; the average surprise was +12.3%. Past results do not predict the next one.

How much does REGN move around earnings?

Over its last 5 reports the stock moved an average of 3.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.

Did Regeneron Pharmaceuticals beat earnings estimates last quarter?